Get started

Inovio

Inovio is turning. INO? Wave A or something else. It is unclear what is forming in this picture exactly, but you can see the momentum shift in the candlesticks. Volatility and parabolism have both turned negative to add fuel to the fire. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe.
NASDAQ:INOShort
by Rykin_Capital
INO What You're Thinking...INO finally broke back above the 786 fib line. Before the last bout of selling, you'll see this level was an area of support for the former penny stock. Now, thanks to some added excitement from delta news (the variant not the airline), INO shares are popping. They also jumped back above the 786 fib. Now the question is, will it rest the 618 fib like it tried to a few weeks ago? "Inovio Pharmaceuticals Inc. (NASDAQ: INO) has steadily climbed for the better part of the last 3 months thanks to recent pipeline progress. In June, the company had expanded its partnership with Advaccine Biopharmaceuticals Suzhou to conduct a Phase 3 segment of a trial called INNOVATE. The goal is to evaluate the safety and efficacy of the company’s INO-4800 in COVID patients. The treatment was already shown to be well tolerated and immunogenic in tested age groups in a Phase 2 study. This month Inovio announced that it and Advaccine received a regulatory allowance for 2 heterologous prime-boost clinical trials in China using INO-4800. “VID-19. If approved, we believe INO-4800 will be well-positioned to serve the vaccine needs of the global community as both a primary and a booster vaccine due to its tolerability, balanced cross-reactive immune responses, and strong thermostability profile that does not require cold or ultra-cold-chain transport,” said Dr. J. Joseph Kim, President, and CEO of INOVIO." Quote Source & Read more on INO: Former Penny Stocks To Watch After Merck’s ( MRK ) Latest FDA Win
NASDAQ:INO
by PennyStocks101
1
Inovio Pharma looks like ready to flip bullishEarnings calls are always kinda of a gamble, but on grand/macro scale $INO looks ready to turn bullish (short to mid term)... Maxx Momentum is signaling a squeeze on D1 and W charts (a squeeze can be in either direction), and KST just signaled a buy on both time frames as well. RSI on daily is a bit extended, while on weekly it sits comfy at the median line. Just looking at some pitchforks as well, the big channel from May low to June High and August Low is holding perfectly and should jump to the upwards. On weekly we are riding 200 EMA and actively flirting with 21 and 25 EMA, trying to flip it over and turning to daily, we can see... That we are just approaching 200 EMA, where we will try to re-claim it as support, with some help of previously mentioned lover EMAs. While I am already long with entry at 8.80, I am looking to add to that long when and if we flip it over with 200 EMA as showed on the chart (flexible entry point around 10.50). I am using 2x lever on both. Obviously if we get the flip, I am adjusting my lower entry SL to higher entries SL, so I cover my possible losses of higher entry with gains from lower entry, which makes this trade extremely low risk. But I do think we have a good chance of visiting 14USD golden zone per share, where I will be closely monitoring live price action, to see if taking partial profits is viable there. If we aggressively pierce through that level, that would be best possible scenario, but I would not be supprised with a V topping formation over there, in that case, RSI on 12h chart will help me address the question of how much partials should I take there and the size of runners towards 16 USD. This risk to rewards ratio is for the taking. Have a great day everyone.
NASDAQ:INOLong
by eriboz
My view on INO Hi Traders, Lets look on INOVIO underneath the hood and see if we can come up with trading idea . Lots of opinions out there some Bullish and some bearish . My approach to this is follow the Money , News ,Gaps . Yes gaps, Reason why I'm using the 1H chart on this is for you to zoom in and see my selected areas in purple and how they worked out in past so you can come up with your opinion on it . I only selected some of them and also added the time frame on it .. I will share multiple approaches with this following the information . So lets start with numbers ..... I Like to point out Short Float on there . Its getting high ! Who is holding and when they got on it . Like to know more > www.nasdaq.com Pointing out 2 the largest multinational investment management companies in USA Black Rock and The Vanguard Group . We also know that they invested end of September and we know the price of the asset . Between me and you lets give them a good deal and call it $11 even . Institutions are holding If you trade INO or holding it we know its pretty volatile but recently its kind of quiet AVG 11M DSV . Information, news and open mind perspective . At first, it was a question who can get their vaccine out first? but I think it's shifted to which vaccine can be distributed easier and faster to administer? At current rate, only 40-60M will be vaccinated by the end of 2021 in US. What's holding them back? each area still have 9X the doses they'd already used so it's not like they ran out. Perhaps the thawing of a vaccine plus the 30mins wait after inoculation to see if any serious allergies provoked? who knows. But keep in mind, these are all healthcare people, it'd be even harder to do the paper work and schedule regular people in to be vaccinated. If every single country started the same time as US, by the end of 2021, we'd have 10%-20% of the world vaccinated. Why $INO is deferent than Famous pump Moderna JJ or others ? ( We can talk about it for long time Imo MRNA will dump at least 50% from here .... ) Inovio Pharmaceuticals reported that Phase 1 clinical trial data evaluating its INO-4800, showed that the COVID-19 vaccine candidate was immunogenic in 100% of the participants and induced neutralizing antibody responses. Shares rose 1.9% on Thursday. In addition, INO-4800 demonstrated favorable safety and tolerability, with no serious adverse events reported, Inovio (INO) said. The vaccine candidate has a best-in-class thermostability, including a five-year projected shelf life at normal refrigeration temperature and requires no frozen transport or storage requirements. "We are very pleased to share peer-reviewed Phase 1 clinical data for INO-4800 published in The Lancet's EClinicalMedicine, and are grateful for the support of all participants and investigator staff involved in the clinical trial," said Inovio CEO Dr. J. Joseph Kim. The Phase 1 clinical data results for Inovio’s COVID-19 DNA vaccine candidate were based on the first cohort of 40 participants in the US aged between 18 to 50. The participants received 1 mg and 2 mg vaccine doses. Each participant was given two doses of INO-4800 four weeks apart. Each dose was administered by intradermal injection using Inovio’s proprietary smart device Cellectra. The 1 mg and 2 mg dose group both demonstrated seroconversion in 95% of the participants, respectively, with 78% showing neutralizing antibodies in the 1 mg dose group and 84% demonstrating neutralizing antibodies in the 2 mg dose group. Yes its only phase 1 (some say it will never finish phase 2) BUT what I like to point out is how smart they play the game in long run ^ text ^ . Ok so we know that now what ... Lets look on 1D . Here you can see areas that I selected based on 1H gaps pre and post market . If you zoom in and look around on your char you will see them . These should be our target zones . 1D looks good and wants me to jump on the trade but I like to point out something . Fact that price shoot up and got rejected to the same spot with in 2 H makes me think about multiple options ... 1/ Some one is closing shorts witch we know are on heavy side .. 2/ MM was trying to pump the price too eliminate some of supply ... BLACK ROCK guys don't like to loose money and they are under the water ~ $1 a share ... 3/ It was just pump and dump ... I know little shallow but its market .. 1D tells me we going up 1H makes me think twice knowing about the gap below and fact that we have lots of shorts in the play with lower target IMO ... Patience here will be a key . If price start to go up from here I will start accumulating and buying the dips with upper target in mind and one above that one . The big gap . If we go lower this week I will place my order at lower gap area and do one stop shop . We will see how this will play out . In my opinion we will have some movement with this ticker very soon . Bears might push this down make people loose their faith and sell and we know how that works . Or we will see pretty good short SQUEEZE ... Let me know what you think . Share your opinion and hit that like button if you like my approach .. Cheers and see you next time .. NASDAQ:INO
NASDAQ:INO
by PTO
10
We are heading down to the 200 EMA (low $16s) on the 4hr chartI expect a trend reversal once we hit the 200 EMA (golden line on bottom) with a slow climb back up. I am labeling this as a Long because it is bearish only for short term. The Stoch RSI has more room to move towards the oversold side but it should not be for more than a day, two max. I expect us to reverse trend from there and move on up with resistance close to $18, $18.90, and finally mid $19s. A close above mid $19s will be really good for long term. I have buys set at $16.30, $16, and $15.80 range. This is not financial advice. Just my opinion based on my analysis of the charts.
NASDAQ:INOLong
by gilbertjohnson2007
INO: only going upLooking at the trends and the candle sticks, I think INO is going up for the coming weeks/months. However, all very much depending on the outcome of the ongoing clinical trial: some results leaked and these were moderately positive (clinicaltrials.gov and www.pharmaceutical-technology.com). If the final results are disappointing or negative, it will go down, fast. Otherwise it will get a boost and easily reach over $30 towards $40. In the mean time I expect it to swing around $22-$24. Wondering what you think? Disclaimer: am a newbie, so also here to learn. Happy to receive constructive feedback.
NASDAQ:INOLong
by swvanderlaan
INO may of found its bottom.As you can see from the simple chart below. INO appears to be back on its path of growth it was on before it went Parabolic on the news that the DoD was buying $70m worth of Inovio vaccine injectors. They are submitting their Phase I trial data to peer reviewed journals (as it always does) on Monday. None of the other vaccine candidates in Operation Warp Speed have peer reviewed studies on any of their CVOID19 candidates. This in combination with being accepted into Operation Warp Speed almost guarantees funding will be coming from Barda or CEPI as every other candidate in OWS has received. What you are seeing here is the MM manipulation knocking out scared retail to buy up the stock. For some context you can see MRNA chart behaved in a near exact way. Peeking at 31 a share on good news of a mouse study before the sell of to ~$18 and then slow steady climb to a ATH $91. INO also behaved in a similar fashion last month on pre-clicincal study where it rocketed the stock to $20 before it sold of back down to $13. This is classic Biotech market behavior.
NASDAQ:INOLong
by Snipervest
4